Minnesota SF 5302: Prescription drugs prices establishment subject to the Medicare Drug Price Negotiation Program

Status: Referred to Health and Human Services (as of 2026-05-16)

State: Minnesota · Session: 2025-2026 · Bill: SF 5302

Subjects: Drugs and Medicine, Health and Health Department

Sponsors: Boldon, Kupec, Maye Quade

View Minnesota SF 5302 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.